200 related articles for article (PubMed ID: 25009318)
21. Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.
Kim JY; Bae BN; Kim KS; Shin E; Park K
Cancer Res Treat; 2009 Mar; 41(1):29-35. PubMed ID: 19688069
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population.
Maver A; Medica I; Salobir B; Tercelj M; Peterlin B
Dis Markers; 2009; 27(6):295-302. PubMed ID: 20075512
[TBL] [Abstract][Full Text] [Related]
23. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
24. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
25. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323
[TBL] [Abstract][Full Text] [Related]
26. SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility.
Chen LZ; He CY; Su X; Peng JL; Chen DL; Ye Z; Yang DD; Wang ZX; Wang F; Shao JY; Xu RH
Gene; 2018 Jan; 640():43-50. PubMed ID: 28962925
[TBL] [Abstract][Full Text] [Related]
27. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract][Full Text] [Related]
28. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population.
Dey S; Ghosh N; Saha D; Kesh K; Gupta A; Swarnakar S
PLoS One; 2014; 9(2):e88040. PubMed ID: 24505369
[TBL] [Abstract][Full Text] [Related]
30. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma.
Fan Y; Zhang X; Yang ZH; Sun XW; Li SN; Zhong L; Cheng X; Wang Y; Ma YR
DNA Cell Biol; 2013 Oct; 32(10):594-600. PubMed ID: 23952692
[TBL] [Abstract][Full Text] [Related]
31. Association of Osteopontin Gene Polymorphisms with Colorectal Cancer.
Kamal A; Darwish RK; Saad S; Salama M; El-Baradie TS; Mahmoud HG; Elshiwy Y
Cancer Invest; 2017 Feb; 35(2):71-77. PubMed ID: 28095066
[TBL] [Abstract][Full Text] [Related]
32. Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms.
Chu M; Yang P; Hou S; Li F; Chen Y; Kijlstra A
Hum Immunol; 2011 Jun; 72(6):525-9. PubMed ID: 21513757
[TBL] [Abstract][Full Text] [Related]
33. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
[TBL] [Abstract][Full Text] [Related]
34. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.
Wang JL; Nong LG; Tang YJ; Wei YS; Yang FL; Wang CF
Med Oncol; 2014 Jul; 31(7):20. PubMed ID: 24913806
[TBL] [Abstract][Full Text] [Related]
35. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
[TBL] [Abstract][Full Text] [Related]
36. Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5
Fu DJ; Wang L; Chouairi FK; Rose IM; Abetov DA; Miller AD; Yamulla RJ; Schimenti JC; Flesken-Nikitin A; Nikitin AY
Nat Commun; 2020 Jan; 11(1):84. PubMed ID: 31901081
[TBL] [Abstract][Full Text] [Related]
37. Effect of ligand
Yuan Y; Liu Q; Zhang F; Luo W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1015-1023. PubMed ID: 33051414
[TBL] [Abstract][Full Text] [Related]
38. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.
Phillips RJ; Helbig KJ; Van der Hoek KH; Seth D; Beard MR
World J Gastroenterol; 2012 Jul; 18(26):3389-99. PubMed ID: 22807608
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.
Iqbal J; Sarkar-Dutta M; McRae S; Ramachandran A; Kumar B; Waris G
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
